Jefferson Hurley, MD
Colon & Rectal Surgery · Irving, TXNPI 1548295355
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 99.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $55,631 and has fallen 89.4% since, to $5,916 in 2025. Among colon & rectal surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $716.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$162K
- Johnson & Johnson$33
- Innovation Technologies Inc$30
- Lilly USA, LLC$28
- Regeneron Healthcare Solutions, Inc.$27
- Activ Surgical, Inc.$27
- plus $133 from 7 others
Across 1 payment — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intuitive Surgical Operations, Inc.$25K
What the payments were for
- Speaking & faculty fees$58,00036%
- Travel & lodging$17,75711%
- Food & beverage$10,5456%
- Education$76,30047%
- Gifts$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 214 | $162,355 |
| Johnson & Johnson | 2 | $33 |
| Innovation Technologies Inc | 1 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Activ Surgical, Inc. | 1 | $27 |
| Shire North American Group Inc | 1 | $24 |
| Conmed Corporation | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $20 |
| TELA Bio, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Solventum Corporation | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$150,864
- DA VINCI SP$9,150
How this compares
$162,632 in reported general payments places this provider in the 95th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 40 | $202 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $164 |
| Metronidazole | 53 | $160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $90 |
| Tramadol Hcl | 28 | $63 |
| Metoclopramide Hcl | 47 | $34 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Irving
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
- Robert JacobsonDallas$125K
- Theodoros VoloyiannisHouston$100K
- Amit AgarwalSugar Land$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.